| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Operating Officer
1 company
Patel Kinnari is a See Remarks at ROCKET PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 2 buys and 2 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2020 | RCKT Rocket Pharmaceuticals, Inc. | Chief Operating Officer | Sell | 16,761 | $56.72 | $950,744.72 | -7.9% | |
| Mar 18, 2020 | RCKT Rocket Pharmaceuticals, Inc. | Chief Operating Officer | Buy | 1,000 | $9.50 | $9,500.00 | +17.6% | |
| Dec 6, 2018 | RCKT Rocket Pharmaceuticals, Inc. | Chief Operating Officer | Buy | 5,675 | $14.98 | $85,011.50 | New |